| # | Title | Journal | Year | Citations |
|---|
| 1 | Protein aggregation and degradation mechanisms in neurodegenerative diseases | American Journal of Neurodegenerative Disease | 2013 | 125 |
| 2 | Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders | American Journal of Neurodegenerative Disease | 2013 | 116 |
| 3 | Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue | American Journal of Neurodegenerative Disease | 2014 | 99 |
| 4 | Immunity and inflammation in neurodegenerative diseases | American Journal of Neurodegenerative Disease | 2013 | 83 |
| 5 | Therapeutic application of melatonin in mild cognitive impairment | American Journal of Neurodegenerative Disease | 2012 | 71 |
| 6 | TRPV1: a stress response protein in the central nervous system | American Journal of Neurodegenerative Disease | 2012 | 70 |
| 7 | Proteolytic processing of the prion protein in health and disease | American Journal of Neurodegenerative Disease | 2012 | 58 |
| 8 | Exosomes-associated neurodegeneration and progression of Parkinson's disease | American Journal of Neurodegenerative Disease | 2012 | 55 |
| 9 | Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress | American Journal of Neurodegenerative Disease | 2012 | 51 |
| 10 | Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: inhibition of inflammation by resolvin D1 | American Journal of Neurodegenerative Disease | 2012 | 50 |
| 11 | Aging, circadian rhythms and depressive disorders: a review | American Journal of Neurodegenerative Disease | 2013 | 50 |
| 12 | Leptin signaling and Alzheimer's disease | American Journal of Neurodegenerative Disease | 2012 | 45 |
| 13 | Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling | American Journal of Neurodegenerative Disease | 2012 | 44 |
| 14 | Differences between early and late onset Alzheimer's disease | American Journal of Neurodegenerative Disease | 2013 | 44 |
| 15 | Age-induced reduction of autophagy-related gene expression is associated with onset of Alzheimer's disease | American Journal of Neurodegenerative Disease | 2014 | 42 |
| 16 | ER-stress in Alzheimer's disease: turning the scale? | American Journal of Neurodegenerative Disease | 2013 | 39 |
| 17 | Tau is reduced in AD plasma and validation of employed ELISA methods | American Journal of Neurodegenerative Disease | 2012 | 37 |
| 18 | Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline | American Journal of Neurodegenerative Disease | 2016 | 36 |
| 19 | The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study | American Journal of Neurodegenerative Disease | 2013 | 35 |
| 20 | Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients | American Journal of Neurodegenerative Disease | 2013 | 35 |
| 21 | C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic | American Journal of Neurodegenerative Disease | 2012 | 32 |
| 22 | Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury in OEF/OIF Veterans | American Journal of Neurodegenerative Disease | 2012 | 26 |
| 23 | Advances in designs for Alzheimer's disease clinical trials | American Journal of Neurodegenerative Disease | 2012 | 26 |
| 24 | Identification of microRNAs involved in Alzheimer's progression using a rabbit model of the disease | American Journal of Neurodegenerative Disease | 2014 | 26 |
| 25 | Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model | American Journal of Neurodegenerative Disease | 2012 | 25 |
| 26 | Retinoid signaling alterations in amyotrophic lateral sclerosis | American Journal of Neurodegenerative Disease | 2012 | 24 |
| 27 | Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson's disease patients as assessed by the Non-Motor Symptoms Questionnaire | American Journal of Neurodegenerative Disease | 2012 | 24 |
| 28 | Copper phenotype in Alzheimer's disease: dissecting the pathway | American Journal of Neurodegenerative Disease | 2013 | 24 |
| 29 | Therapies for human prion diseases | American Journal of Neurodegenerative Disease | 2013 | 24 |
| 30 | Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats | American Journal of Neurodegenerative Disease | 2016 | 24 |
| 31 | GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16 | American Journal of Neurodegenerative Disease | 2013 | 23 |
| 32 | Can zebrafish be used as animal model to study Alzheimer's disease? | American Journal of Neurodegenerative Disease | 2012 | 22 |
| 33 | Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease | American Journal of Neurodegenerative Disease | 2012 | 22 |
| 34 | Circulating progranulin as a biomarker for neurodegenerative diseases | American Journal of Neurodegenerative Disease | 2012 | 21 |
| 35 | Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease | American Journal of Neurodegenerative Disease | 2012 | 21 |
| 36 | C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity | American Journal of Neurodegenerative Disease | 2014 | 21 |
| 37 | Greater loss of von Economo neurons than loss of layer II and III neurons in behavioral variant frontotemporal dementia | American Journal of Neurodegenerative Disease | 2014 | 21 |
| 38 | The time course of action of two neuroprotectants, dietary saffron and photobiomodulation, assessed in the rat retina | American Journal of Neurodegenerative Disease | 2013 | 20 |
| 39 | Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease | American Journal of Neurodegenerative Disease | 2015 | 20 |
| 40 | Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina | American Journal of Neurodegenerative Disease | 2012 | 19 |
| 41 | Alzheimer's disease biomarkers in animal models: closing the translational gap | American Journal of Neurodegenerative Disease | 2013 | 19 |
| 42 | Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations | American Journal of Neurodegenerative Disease | 2013 | 19 |
| 43 | Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model | American Journal of Neurodegenerative Disease | 2017 | 19 |
| 44 | Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease | American Journal of Neurodegenerative Disease | 2012 | 18 |
| 45 | Microglial chemotactic signaling factors in Alzheimer's disease | American Journal of Neurodegenerative Disease | 2012 | 18 |
| 46 | Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease | American Journal of Neurodegenerative Disease | 2012 | 17 |
| 47 | Effect of fish oil on glutathione redox system in multiple sclerosis | American Journal of Neurodegenerative Disease | 2016 | 17 |
| 48 | The protective effects of crocin in the management of neurodegenerative diseases: a review | American Journal of Neurodegenerative Disease | 2018 | 15 |
| 49 | Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-β precursor protein dimerization | American Journal of Neurodegenerative Disease | 2012 | 14 |
| 50 | Optineurin immunoreactivity in neuronal and glial intranuclear inclusions in adult-onset neuronal intranuclear inclusion disease | American Journal of Neurodegenerative Disease | 2014 | 14 |
